Figure 3.
Statistical analysis of immunohistochemistry data showed that the percentage of A1R-positive cells was significantly increased in the SE group compared with the con group. Treatment with the p38 MAPK inhibitor SB203580 (15 mg/kg) decreased the expression levels of A1R compared with SE group. n=5 in each group. *P<0.05 vs. con; #P<0.05 vs. SE. A1R, adenosine A1 receptor; SE, status epilepticus; con, control.